hearing evaluation in oropharyngeal cancer patients
Phase 2
- Conditions
- Health Condition 1: C109- Malignant neoplasm of oropharynx,unspecifiedHealth Condition 2: null- oropharyngeal cancers
- Registration Number
- CTRI/2019/02/017526
- Lead Sponsor
- DR Lokeswari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
•Histo pathologically proven oropharyngeal cancers.
•Karnofsky performance status above 70
•Stage III-IVB carcinoma oropharynx planned for curative treatments.
•Patients willing for informed consent and regular follow up
•No previous history of hearing loss
Exclusion Criteria
•Patients who have received previous chemoradiotherapy.
•Patients with significant pre-existing congenital or acquired hearing loss.
•Patient co- morbid conditions like hypertension, diabetes or any renal impairment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of hearing evaluationTimepoint: Evaluation of hearing status at 6 weeks ,3 months and 6 months of completion of radiation therapy
- Secondary Outcome Measures
Name Time Method ocal controlTimepoint: 6 months